With multi-resistant germs becoming more and more of a threat, we are in need of new antibiotics now more than ever. Unfortunately, antibiotics cannot distinguish between pathogens and beneficial microbes. They can destroy the delicate balance of the microbiome – resulting in permanent damages. The research team around chemist Dr Thomas Böttcher has now made a significant step towards solving these problems. In collaboration with the team around biologist Professor Christof Hauck, also from Konstanz, the researchers discovered antibiotic properties of a natural product that so far had been considered merely a bacterial signal molecule. The team, including the doctoral researchers Dávid Szamosvári and Tamara Schuhmacher, developed and investigated synthetic derivatives of the natural substance that proved surprisingly efficient against the pathogen Moraxella catarrhalis. In the process only the growth of these pathogens was inhibited, not the growth of other bacteria. In a further project, the researchers succeed in developing another selective agent to combat the malaria parasite. These results might lead to a new basis for novel precision antibiotics. The research results are published in the current editions of the journals Chemical Science and Chemical Communications.
As important as antibiotics are to treat infectious diseases, they leave a trail of destruction in the human microbiome. Gastrointestinal disorders following antibiotic treatments are one of the slightest problems in this context. Quite often, resistant pathogens replace beneficial microbes. Later on, these can cause severe infectious diseases or chronic illnesses. However, not all microbes are dangerous. On the contrary, many microorganisms live in peaceful coexistence with us, and are even vital for human health. We humans are true microcosms and host more microbes than human cells. Yet this ecosystem, the human microbiome, is fragile. Allergies, overweight, chronic inflammatory bowel diseases and even psychiatric disorders may be the result of a damaged microbiome. The question is how can we maintain this ecological diversity in case of a microbial infection?
The research team originally studied the signals of the bacterium Pseudomonas aeruginosa. A compound aroused their interest as it was highly selectively inhibiting the growth of the pathogen Moraxella catarrhalis. This pathogen causes, for example, otitis media in children as well as infections in patients with chronically obstructive pulmonary diseases. The synthetic scaffold engineering of this natural product resulted in a new compound class with enormous antibiotic efficiency. What was really surprising was the substance’s selectivity: Only the growth of Moraxella catarrhalis was inhibited, not that of other bacteria. Even closely related bacteria from the same species remained completely unaffected.
Currently, Thomas Böttcher and Christof Hauck are investigating the mechanism of action of this highly selective antibiotic against the pathogen Moraxella catarrhalis. Antibiotics with such selectivity would make precision treatment possible and specifically eliminate pathogens while preserving the diversity of beneficial microbes.
Learn more: Selective antibiotics following nature’s example
The Latest on: Precision antibiotics
via Google News
The Latest on: Precision antibiotics
- Precision Health and Well-Being: What Is It and Why Should We Care?on January 21, 2021 at 1:48 pm
To ensure the promise of precision lives up to expectations, as an industry, we'll need to overcome these three important challenges.
- Precision Medicine Market SWOT Analysis by Size, Status and Forecast to 2020-2026: Illumina, Roche, Abbott Laboratorieson January 19, 2021 at 11:45 am
The Global Precision Medicine Market has witnessed continuous growth in the past few years and may grow further during the forecast period (2020-2026).
- How One Million Volunteers Could One Day Revolutionize Medicineon January 19, 2021 at 10:00 am
A bold NIH program promises groundbreaking insights into some of the nation’s deadliest diseases. Researchers want hundreds of thousands of volunteers to get involved.
- Dr. Narla on Advances Made With Precision Medicine in Oncologyon January 18, 2021 at 4:17 pm
Goutham Narla, MD, PhD, discusses advances made with precision medicine in oncology. Goutham Narla, MD, PhD, an associate professor in the Department of Medicine; chief of the Division of Genetic ...
- Precision Medicine Market Size is Expected to Reach USD 141.33 Billion by 2027on January 18, 2021 at 2:28 am
The precision medicine market size was surpassed USD 59.16 billion in 2019 and expected to reach USD 141.33 billion by 2027 and growing at impressive CAGR of 11.5% during the forecast period 2020 to ...
- Precision Medicine Group Significantly Expands Cell And Gene Therapy Expertise With Acquisition Of Project Farmaon January 14, 2021 at 6:05 am
PRNewswire/ -- Precision Medicine Group ("PMG") announced today it has acquired Project Farma, a patient-focused bioengineering services firm that ...
- Diabetes research in era of precision medicine, Covidon January 12, 2021 at 1:26 pm
Diabetes is a major healthcare challenge and priority in Qatar, with its prevalence currently at 17% ? twice the global average. Ten percent of diabetes cases are type 1 (T1D) and 90% are type 2 (T2D) ...
- Precision Medicine Market- Competitive Scenario, Strategic Management, Massive Growth, and Developments in the Market, 2027on January 12, 2021 at 6:10 am
Recent report published by research nester titled "Precision Medicine Market: Global Demand Analysis & Opportunity Outlook 2027"delivers the detailed overview of the global precision medicine market ...
- Precision Medicine Market: Growth Opportunities, Current and Projected Market Size, Recent Industry Trends and Developments 2025on January 11, 2021 at 11:09 pm
Jan (Heraldkeepers) -- Precision Medicine Market Research Report: Information by Ecosystem Players (Pharmaceuticals and Biotechnology ...
- Potential jurors favor use of artificial intelligence in precision medicineon January 11, 2021 at 1:14 pm
Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the U ...
via Bing News